Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance

HLA Class II Antigen Expression in Colorectal Carcinoma Tumors as a Favorable Prognostic Marker

(2015) Giuseppe Sconocchia et al.   NEOPLASIA

Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition

(2014) A B del Campo et al.   CANCER GENE THERAPY

A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines

(2014) Sebastian Boegel et al.   OncoImmunology

Correlation of Serum β2-Microglobulin Levels with Prostate-specific Antigen, Gleason Score, Clinical Stage, Tumor Metastasis and Therapy Efficacy in Prostate Cancer

(2013) Yun-xin Zhang et al.   ARCHIVES OF MEDICAL RESEARCH

Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma

(2013) Ana B. del Campo et al.   INTERNATIONAL JOURNAL OF CANCER

Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes

(2012) Monica Bernal et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

NLRC5 Controls Basal MHC Class I Gene Expression in an MHC Enhanceosome-Dependent Manner

(2012) A. Neerincx et al.   JOURNAL OF IMMUNOLOGY

Targeting HLA class I expression to increase tumor immunogenicity

(2012) A. B. del Campo et al.   TISSUE ANTIGENS

Killing tumor cells through their surface β2-microglobulin or major histocompatibility complex class I molecules

(2010) Jing Yang et al.   CANCER

Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors

(2010) Isabel Maleno et al.   IMMUNOGENETICS

Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells

(2010) Rafael Carretero et al.   INTERNATIONAL JOURNAL OF CANCER

Beta-2-microglobulin expression correlates with high-grade prostate cancer and specific defects in androgen signaling

(2010) Sheldon R. Mink et al.   PROSTATE

Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer

(2009) Barbara Seliger et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells

(2009) Yuqing Shen et al.   MOLECULAR IMMUNOLOGY

Efficient Recovery of HLA Class I Expression in Human Tumor Cells After Beta2-Microglobulin Gene Transfer Using Adenoviral Vector: Implications for Cancer Immunotherapy

(2009) A. B. del Campo et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

(2008) Natalia Aptsiauri et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY